Patent · US Active

Salts of an epidermal growth factor receptor kinase inhibitor

US9108927B2 · kind B2 · utility

9Cited by
58References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2013
Grant dateAug 18, 2015
Priority date
Expiry dateMar 13, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.